G. Karacetin Et Al. , "BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders," EUROPEAN JOURNAL OF PSYCHIATRY , vol.36, no.1, pp.26-34, 2022
Karacetin, G. Et Al. 2022. BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders. EUROPEAN JOURNAL OF PSYCHIATRY , vol.36, no.1 , 26-34.
Karacetin, G., BAYOĞLU, B., Soylemez, T. E., Topal, M., Koc, E. B., Tekden, M., ... Ermis, C.(2022). BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders. EUROPEAN JOURNAL OF PSYCHIATRY , vol.36, no.1, 26-34.
Karacetin, G. Et Al. "BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders," EUROPEAN JOURNAL OF PSYCHIATRY , vol.36, no.1, 26-34, 2022
Karacetin, G. Et Al. "BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders." EUROPEAN JOURNAL OF PSYCHIATRY , vol.36, no.1, pp.26-34, 2022
Karacetin, G. Et Al. (2022) . "BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders." EUROPEAN JOURNAL OF PSYCHIATRY , vol.36, no.1, pp.26-34.
@article{article, author={G. Karacetin Et Al. }, title={BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders}, journal={EUROPEAN JOURNAL OF PSYCHIATRY}, year=2022, pages={26-34} }